InsiderClue
Insiders · Profile

Fairmount Funds Management LLC

Director at CRESCENT BIOPHARMA · Director at Oruka Therapeutics · Director at Spyre Therapeutics · and 5 more. Filing since 21 Sep 2021. CIK 0001802528

CBIO CRESCENT BIOPHARMA, INC. Director · 2 trades ORKA Oruka Therapeutics, Inc. Director · 1 trade SYRE Spyre Therapeutics, Inc. Director · 1 trade VRDN Viridian Therapeutics, Inc.\DE Director · 6 trades COGT Cogent Biosciences, Inc. Director · 5 trades ZBIO Zenas BioPharma, Inc. Director · 3 trades APGE Apogee Therapeutics, Inc. Director · 2 trades DNTH Dianthus Therapeutics, Inc. /DE/ Director · 5 trades
Company
Date
Role
Action
Shares
Amount
Of holding
CBIO CRESCENT BIOPHARMA, INC.
16 Jul 2026
Director
Bought
853,450
$12.38M
31.1%
ORKA Oruka Therapeutics, Inc.
1 Jul 2026
Director
Sold at will
3,553,410
$300.01M
75.8%
SYRE Spyre Therapeutics, Inc.
23 Jun 2026
Director
Sold at will
4,684,781
$399.66M
100%
VRDN Viridian Therapeutics, Inc.\DE
11 May 2026
Director
Bought
1,176,470
$20.00M
30.1%
COGT Cogent Biosciences, Inc.
31 Mar 2026
Director
Sold at will
7,000,000
$242.62M
56.0%
ZBIO Zenas BioPharma, Inc.
31 Mar 2026
Director
Bought
150,000
$3.00M
6.8%
APGE Apogee Therapeutics, Inc.
22 Jan 2026
Director
Sold at will
1,750,000
$133.53M
85.4%
COGT Cogent Biosciences, Inc.
22 Jan 2026
Director
Sold at will
3,500,000
$127.40M
38.9%
CBIO CRESCENT BIOPHARMA, INC.
4 Dec 2025
Director
Bought
1,360,000
$18.24M
98.0%
VRDN Viridian Therapeutics, Inc.\DE
23 Oct 2025
Director
Bought
454,545
$10.00M
13.1%
ZBIO Zenas BioPharma, Inc.
7 Oct 2025
Director
Bought
316,219
$6.01M
16.7%
COGT Cogent Biosciences, Inc.
10 Jul 2025
Director
Bought
2,777,777
$25.00M
44.6%
ZBIO Zenas BioPharma, Inc.
16 Sep 2024
Director
Bought
300,000
$5.10M
23.0%
VRDN Viridian Therapeutics, Inc.\DE
13 Sep 2024
Director
Bought
1,600,000
$30.00M
86.7%
VRDN Viridian Therapeutics, Inc.\DE
22 Jan 2024
Director
Bought
476,190
$10.00M
34.9%
DNTH Dianthus Therapeutics, Inc. /DE/
29 Sep 2023
Director
Bought
24,670
$336.25K
1.3%
DNTH Dianthus Therapeutics, Inc. /DE/
26 Sep 2023
Director
Bought
30,000
$394.50K
1.6%
DNTH Dianthus Therapeutics, Inc. /DE/
19 Sep 2023
Director
Bought
30,000
$396.00K
1.6%
DNTH Dianthus Therapeutics, Inc. /DE/
13 Sep 2023
Director
Bought
9,367
$110.16K
0.5%
DNTH Dianthus Therapeutics, Inc. /DE/
12 Sep 2023
Director
Bought
14,887
$161.52K
0.8%
APGE Apogee Therapeutics, Inc.
13 Jul 2023
Director
Bought
2,941,176
$50.00M
opened
COGT Cogent Biosciences, Inc.
9 Jun 2023
10% owner
Bought
800,000
$9.60M
32.4%
VRDN Viridian Therapeutics, Inc.\DE
17 Aug 2022
Director
Bought
425,531
$10.00M
45.4%
COGT Cogent Biosciences, Inc.
16 Jun 2022
10% owner
Bought
1,200,000
$9.90M
94.3%
VRDN Viridian Therapeutics, Inc.\DE
21 Sep 2021
Director
Bought
909,000
$10.00M
×31
25 decisions on file.